Natixis’s Omega Protein OME Stock Holding History

Natixis’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-20,600	Closed	-$185K	–	588
2013 Q2	$185K	Buy	+20,600	New	+$207K	﹤0.01%	410

Other funds holding OME

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Natixis's OME Position: Q3 2013 in Review

Natixis sold out of Omega Protein (OME) in Q3 2013, closing a stake of 20,600 shares — an estimated $185K sold.

Natixis first reported a position in OME in Q2 2013 and held it in 1 quarter. The position peaked at $185K in Q2 2013. 104 funds tracked by Wall St. Rank hold OME as of Q3 2013.

Natixis reported no remaining Omega Protein position as of Q3 2013 after selling out during the quarter.
Natixis sold 20,600 Omega Protein shares in Q3 2013, an estimated $185K.
Natixis first reported a position in Omega Protein in Q2 2013 and held it in 1 quarter.
Natixis's Omega Protein position peaked at $185K in Q2 2013.
104 funds tracked by Wall St. Rank held Omega Protein as of Q3 2013.

Based on Natixis's 13F filing for Q3 2013, filed 14 Nov 2013.